Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era-Reference-Cited by-同舟云学术

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era

Published:2018-06-14 Issue:11 Volume:36 Page:1767-1774
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Fletcher Sean A.,Harmouch Sabrina S.,Krimphove Marieke J.,Cole Alexander P.,Berg Sebastian,Gild Philipp,Preston Mark A.,Sonpavde Guru P.,Kibel Adam S.,Sun Maxine,Choueiri Toni K.,Trinh Quoc-Dien^ORCID

Funder

Brigham Research Institute Fund to Sustain Research Excellence

Bruce A. Beal and Robert L. Beal Surgical Fellowship

Genentech Bio-Oncology Career Development Award from the Conquer Cancer Foundation of the American Society of Clinical Oncology

Health Services Research pilot test grant from the Defense Health Agency

Clay Hamlin Young Investigator Award from the Prostate Cancer Foundation

Unrestricted Educational Grant from the Vattikuti Urology Institute

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/article/10.1007/s00345-018-2371-y/fulltext.html

Reference30 articles.

1. Leow JJ, Cole AP, Seisen T et al. (2017) Variations in the costs of radical cystectomy for bladder cancer in the USA. Eur Urol. https://doi.org/10.1016/j.eururo.2017.07.016

2. Svatek RS, Hollenbeck BK, Holmang S et al (2014) The economics of bladder cancer: costs and considerations of caring for this disease. Eur Urol 66(2):253–262

3. Cole AP, Dalela D, Hanske J et al (2015) Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988–2010. Urol Oncol 33(12):504 e509–517

4. Leow JJ, Reese S, Trinh QD et al (2015) Impact of surgeon volume on the morbidity and costs of radical cystectomy in the USA: a contemporary population-based analysis. BJU Int 115(5):713–721

5. Chang SS, Bochner BH, Chou R et al (2017) Treatment of non-metastatic muscle-invasive bladder cancer: AUA/ASCO/ASTRO/SUO guideline. J Urol 198(3):552–559

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older;Frontiers in Oncology;2024-05-15

2. Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer;Urologic Oncology: Seminars and Original Investigations;2022-06

3. Non‐metastatic muscle‐invasive bladder cancer: the role of age in receiving treatment with curative intent;BJU International;2022-02-08

4. Treatment Discontinuation in Patients With Muscle-Invasive Bladder Cancer Undergoing Chemoradiation;Advances in Radiation Oncology;2022-01

5. Comparative study of postoperative complications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains associated with significant postoperative morbidities;Urologic Oncology: Seminars and Original Investigations;2022-01